Trifluoroacetic Acid

Trifluoroacetic Acid

SCHEMBL1727596

CC#N.CC#N.CC#N.CC#N.CC#N.CC#N.CC#N.CC#N.CC#N.CC#N.CC#N.CC#N.CC#N.CC#N.CC#N.CC#N.CC#N.CC#N.CC#N.CC#N.CC#N.CC#N.CC#N.CC#N.CC#N.CC#N.CC#N.CC#N.CC#N.CC#N.CC#N.CC#N.CC#N.CC#N.CC#N.CC#N.CC#N.CC#N.CC#N.CC#N.CC#N.CC#N.CC#N.CC#N.CC#N.CC#N.CC#N.CC#N.CC#N.CC#N.CC#N.CC#N.CC#N.CC#N.CC#N.CC#N.CC#N.CC#N.CC#N.CC#N.CC#N.CC#N.CC#N.CC#N.CC#N.CC#N.CC#N.CC#N.CC#N.CC#N.CC#N.CC#N.CC#N.CC#N.CC#N.CC#N.CC#N.CC#N.CC#N.CC#N.O=C(O)C(F)(F)F.O=C(O)C(F)(F)F.O=C(O)C(F)(F)F.O=C(O)C(F)(F)F.O=C(O)C(F)(F)F.O=C(O)C(F)(F)F.O=C(O)C(F)(F)F.O=C(O)C(F)(F)F.O=C(O)C(F)(F)F.O=C(O)C(F)(F)F.O=C(O)C(F)(F)F.O=C(O)C(F)(F)F.O=C(O)C(F)(F)F.O=C(O)C(F)(F)F.O=C(O)C(F)(F)F.O=C(O)C(F)(F)F.O=C(O)C(F)(F)F.O=C(O)C(F)(F)F.O=C(O)C(F)(F)F.O=C(O)C(F)(F)F

nearest known ligand 0.35

Full drug profile on Sugi Atlas →

Predicted protein targets (top 8)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 3/20 0.35
TSHR P16473 2/20 0.35
L3MBTL1 Q9Y468 1/20 0.33
DPP4 P27487 1/20 0.33
DPP8 Q6V1X1 1/20 0.33
THRB P10828 1/20 0.32
CA2 P00918 1/20 0.30
TP53 P04637 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Trifluoroacetic Acid SCHEMBL140346 1.00 ALDH1A1 (0.35) ALDH1A1TSHRL3MBTL1DPP4DPP8
Trifluoroacetic Acid SCHEMBL27934780 1.00 ALDH1A1 (0.35) ALDH1A1TSHRL3MBTL1DPP4DPP8
Trifluoroacetic Acid SCHEMBL8009450 1.00 ALDH1A1 (0.35) ALDH1A1TSHRL3MBTL1DPP4DPP8
Trifluoroacetic Acid SCHEMBL4287600 1.00 ALDH1A1 (0.35) ALDH1A1TSHRL3MBTL1DPP4DPP8
Trifluoroacetic Acid SCHEMBL4355857 1.00 ALDH1A1 (0.35) ALDH1A1TSHRL3MBTL1DPP4DPP8
Trifluoroacetic Acid SCHEMBL3833376 1.00 ALDH1A1 (0.35) ALDH1A1TSHRL3MBTL1DPP4DPP8
Trifluoroacetic Acid SCHEMBL5745817 1.00 ALDH1A1 (0.35) ALDH1A1TSHRL3MBTL1DPP4DPP8
Trifluoroacetic Acid SCHEMBL128012 1.00 ALDH1A1 (0.35) ALDH1A1TSHRL3MBTL1DPP4DPP8
Trifluoroacetic Acid SCHEMBL18095558 0.97 ALDH1A1 (0.33) ALDH1A1TSHRL3MBTL1DPP4DPP8
Trifluoroacetic Acid SCHEMBL4296530 0.97 ALDH1A1 (0.33) ALDH1A1TSHRL3MBTL1DPP4DPP8

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 23 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-117213385-A Method for detecting and quantifying An Zhuokui Nol in Antrodia camphorata solid state fermentation product 江苏神力特生物科技股份有限公司 2023-12-12 CN disclosed
EP-2716641-B1 RADIOACTIVE IODINE LABELED COMPOUND HAVING AFFINITY FOR AMYLOID NIHON MEDIPHYSICS CO LTD (JP) 2017-04-05 EP disclosed
CN-103769060-B For adsorbent and the Preparation method and use of bacteria removal endotoxin, DNA and peptide glycan CHONGQING ANTI NEW BIOTECHNOLOGY CO., LTD. (CN) 2015-10-21 CN disclosed
US-9149546-B2 Compound having affinity for amyloid NIHON MEDI-PHYSICS CO., LTD. (JP) 2015-10-06 US disclosed
US-20140228569-A1 NOVEL COMPOUND HAVING AFFINITY FOR AMYLOID NIHON MEDI-PHYSICS CO., LTD. (JP) 2014-08-14 US disclosed
CN-103769060-A Adsorbent for removing bacterial endotoxin, DNA and peptidoglycan and preparation method and use ZHENG YUE 2014-05-07 CN disclosed
US-8506930-B2 Compounds having affinity for amyloid NIHON MEDI-PHYSICS CO., LTD. (JP) 2013-08-13 US disclosed
US-8303935-B2 Alkoxy substituted imidazo[1,2-a]pyridines having affinity for amyloid NIHON MEDI-PHYSICS CO., LTD. (JP) 2012-11-06 US disclosed
US-20120271053-A1 NOVEL COMPOUND HAVING AFFINITY FOR AMYLOID NIHON MEDI-PHYSICS CO., LTD. (JP) 2012-10-25 US disclosed
WO-2011029443-A8 DEVICE FOR A MULTIPLE SOCKET FOR RECEIVING PLUG CONNECTIONS HOHENADEL THORSTEN (DE) 2012-05-10 WO disclosed
EP-2022792-B1 NOVEL COMPOUND HAVING AFFINITY TO AMYLOID NIHON MEDIPHYSICS CO LTD (JP) 2010-12-29 EP disclosed
US-20100249407-A1 Novel Compound Having Affinity to Amyloid NIHON MEDI-PHYSICS CO., LTD. (JP) 2010-09-30 US disclosed
US-20090252679-A1 Novel Compound Having Affinity for Amyloid NIHON MEDI-PHYSICS CO., LTD. (JP) 2009-10-08 US disclosed
US-20090252680-A1 NOVEL COMPOUND WITH AFFINITY FOR AMYLOID NIHON- MEDI-PHYSICS CO., LTD (JP) 2009-10-08 US disclosed
CN-101535309-A Novel compound having affinity for amyloid NIHON MEDIPHYSICS CO LTD (JP) 2009-09-16 CN disclosed
EP-2098523-A1 NOVEL COMPOUNDS WITH AFFINITY FOR AMYLOID NIHON MEDI-PHYSICS CO., LTD. (JP) 2009-09-09 EP disclosed
CN-101472923-A Novel compound having affinity to amyloid NIHON MEDIPHYSICS CO LTD (JP) 2009-07-01 CN disclosed
CN-101466711-A Novel compound having affinity for amyloid NIHON MEDIPHYSICS CO LTD (JP) 2009-06-24 CN disclosed
EP-2022792-A1 NOVEL COMPOUND HAVING AFFINITY TO AMYLOID NIHON MEDI-PHYSICS CO., LTD. (JP) 2009-02-11 EP disclosed
EP-2019103-A1 NOVEL COMPOUND HAVING AFFINITY FOR AMYLOID NIHON MEDI-PHYSICS CO., LTD. (JP) 2009-01-28 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (5 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20140228569-A1 NOVEL COMPOUND HAVING AFFINITY FOR AMYLOID APP, APBA1, BACE1 ALDH1A1 1827/4885TSHR 1527/4885L3MBTL1 1339/4885
US-20100249407-A1 Novel Compound Having Affinity to Amyloid APBA1, APP, BACE1 ALDH1A1 942/4885TSHR 1510/4885L3MBTL1 187/4885
US-20090252680-A1 NOVEL COMPOUND WITH AFFINITY FOR AMYLOID APBA1, APP, SLC7A1 ALDH1A1 1302/4885TSHR 1795/4885L3MBTL1 1523/4885
US-20090252679-A1 Novel Compound Having Affinity for Amyloid APBA1, SAAL1, SLC43A1 ALDH1A1 1324/4885TSHR 1244/4885L3MBTL1 91/4885
US-20120271053-A1 NOVEL COMPOUND HAVING AFFINITY FOR AMYLOID APBA1, SAAL1, SLC43A1 ALDH1A1 1324/4885TSHR 1244/4885L3MBTL1 91/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.